| Andrew Marthy, MD | |
|
113 Gainsborough Sq Ste 400, Chesapeake, VA 23320-1714 | |
| (757) 842-4499 | |
| Not Available |
| Full Name | Andrew Marthy |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 113 Gainsborough Sq Ste 400, Chesapeake, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609230176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 0101271002 (Virginia) | Primary |
| Entity Name | Winchester Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679711261 PECOS PAC ID: 0244134021 Enrollment ID: O20031124000061 |
News Archive
Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.
The Center for Advanced Breast Care is the first comprehensive breast center in the Chicago area to add Positron Emission Mammography-guided biopsy capability to its already extensive breast cancer care services.
Lawyers for doctor-owned hospitals will make the case today that the health law unfairly curbs their business model before a judge in Tyler, Texas, the Austin American-Statesman reports.
A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.
› Verified 7 days ago
| Entity Name | Valley Physician Enterprise Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538316203 PECOS PAC ID: 9931268091 Enrollment ID: O20081104000278 |
News Archive
Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.
The Center for Advanced Breast Care is the first comprehensive breast center in the Chicago area to add Positron Emission Mammography-guided biopsy capability to its already extensive breast cancer care services.
Lawyers for doctor-owned hospitals will make the case today that the health law unfairly curbs their business model before a judge in Tyler, Texas, the Austin American-Statesman reports.
A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.
› Verified 7 days ago
| Entity Name | Chesapeake Regional Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699940270 PECOS PAC ID: 8426113663 Enrollment ID: O20090223000187 |
News Archive
Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.
The Center for Advanced Breast Care is the first comprehensive breast center in the Chicago area to add Positron Emission Mammography-guided biopsy capability to its already extensive breast cancer care services.
Lawyers for doctor-owned hospitals will make the case today that the health law unfairly curbs their business model before a judge in Tyler, Texas, the Austin American-Statesman reports.
A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Marthy, MD Walter Reed National Military Ctr, 8901 Wisconsin Avenue, Bethesda, MD 20889-5600 Ph: () - | Andrew Marthy, MD 113 Gainsborough Sq Ste 400, Chesapeake, VA 23320-1714 Ph: (757) 842-4499 |
News Archive
Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.
The Center for Advanced Breast Care is the first comprehensive breast center in the Chicago area to add Positron Emission Mammography-guided biopsy capability to its already extensive breast cancer care services.
Lawyers for doctor-owned hospitals will make the case today that the health law unfairly curbs their business model before a judge in Tyler, Texas, the Austin American-Statesman reports.
A Food and Drug Administration (FDA) panel created history by recommending a gene therapy for patients with cancer. In this therapy the patient's own genes would be modified to fight the cancer cells. The patient's cells which are thus altered to treat the cancer would thus be termed as "living drugs" as they act as soldiers to treat the cancer. These cells boost up the immune system and help the body fight the cancer.
› Verified 7 days ago
Dr. Mohib N I Ghobrial, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 109c Wimbledon Square, Chesapeake, VA 23320 Phone: 757-436-3630 Fax: 757-312-0815 | |
Dr. Stephen Hsiang-han Lin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 Gainsborough Sq, Suite 400, Chesapeake, VA 23320 Phone: 757-842-4499 Fax: 757-842-4490 | |
Dr. Robert Joseph Chastanet, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Chesapeake Weight Loss, 221 Mt. Pleasant Road, Chesapeake, VA 23322 Phone: 757-312-9444 Fax: 757-447-3500 | |
Dr. Wei Wei, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 Gainsborough Sq Ste 400, Chesapeake, VA 23320 Phone: 757-842-4499 Fax: 757-842-4490 | |
Dr. Thomas Preston Davis, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1148 Kingsbury Dr, Chesapeake, VA 23322 Phone: 757-546-8013 | |
Stephanie K Repole, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 844 Battlefield Blvd N Ste 100, Chesapeake, VA 23320 Phone: 757-312-3033 | |
David D. Spencer, D.O Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 Gainsborough Sq, Ste 400, Chesapeake, VA 23320 Phone: 757-842-4499 Fax: 757-842-1447 |